UBS Group’s Acacia Research ACTG Stock Holding History

UBS Group’s Portfolio ACTG Stock Details ACTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,000	Closed	-$68K	–	8724
2014 Q4	$68K	Buy	+4,000	New	+$69.2K	﹤0.01%	6100

Other funds holding ACTG

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

UBS Group's ACTG Position: Q1 2026 in Review

UBS Group reduced its Acacia Research (ACTG) stake by 6.4% in Q1 2026, selling an estimated $33.6K and leaving 116,072 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #6005.

UBS Group first reported a position in ACTG in Q4 2014 and has held it in 43 quarters since. 118 funds tracked by Wall St. Rank hold ACTG as of Q1 2026.

UBS Group held 116,072 shares of Acacia Research worth $558K as of Q1 2026.
UBS Group sold 7,968 Acacia Research shares in Q1 2026, an estimated $33.6K.
Acacia Research made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6005 holding.
UBS Group first reported a position in Acacia Research in Q4 2014 and has held it in 43 quarters since.
118 funds tracked by Wall St. Rank held Acacia Research as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.